Listed below are brief descriptions of the CAMH platform technologies that are available for licensing. Follow the links to read a non-confidential summary of each technology.
Feel free to contact our office should you require more information or wish inquire about the first steps in securing a licensing deal.Technology for Large-Scale DNA Methylation Profiling
Our scientists have developed a biomarker discovery platform that allows for genome-wide interrogation of methylation patterns in small DNA samples. The technology is a restriction enzyme-based assay that uses adaptor-specific PCR to amplify the DNA fraction of interest and compare methylation profiles of different samples using microarray technology. Click here
to read more.